Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

23. October 2018 - 21:01 (CEST)

Epigenomics AG successfully completes capital increase; gross proceeds of EUR 22.3 million

Read more

16. October 2018 - 10:17 (CEST)

Epigenomics AG sets subscription price at EUR 1.86 per new share

Read more

03. October 2018 - 17:05 (CEST)

Epigenomics AG plans to increase share capital with subscription rights for existing shareholders / Commitment of major shareholder to participate in planned capital increase

Read more

Press releases

17. June 2019

New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome

Read more

04. June 2019

Epigenomics AG to Participate in Raymond James Life Sciences and MedTech Conference in June

Read more

20. May 2019

New Report Shows CRC Screening Rates Increased When a Medically Underserved Population is Offered Epi proColon® Blood Test

Read more